PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME

Detalles Bibliográficos
Autores principales: Ogbogu, Princess, Klion, Amy, Roufosse, Florence, Akuthota, Praveen, Khoury, Paneez, Shih, Vivian, Griffis, Dianne, Parikh, Himanshu, Chen, Ron, Fan, Ying, Mayer, Gaell, Jain, Priya, Katial, Rohit, Psallidas, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429737/
http://dx.doi.org/10.1097/01.HS9.0000975660.56238.59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429737/
http://dx.doi.org/10.1097/01.HS9.0000975660.56238.59

Ejemplares similares